Atlas Trials

How the Precise Habitats Can Predict the IDH Mutation Status and Prognosis of the Patients With High-grade Gliomas

Clinical trial NCT04908267 · UNKNOWN

Trial details

NCT number
NCT04908267
Sponsor
Weiguo Zhang
Status
UNKNOWN
Study type
OBSERVATIONAL
High-grade Glioma
Start date
2022-08-01
Primary completion
2024-12-31
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.